Cam Gallagher Ocuphire Pharma, Inc. (OCUP) insider trading activity

Cam Gallagher is of Ocuphire Pharma, Inc.. Currently has a direct ownership of 1.81 Million shares of OCUP, which is worth approximately $1.77 Million. The most recent transaction as insider was on Aug 25, 2025, when has been sold 869,565 shares (Common Stock) at a price of $1.15 per share, resulting in proceeds of $999,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.81M

92.42% 3M change

2249.77% 12M change

Total Value Held $1.77 Million

Cam Gallagher Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 25 2025	BUY Grant, award, or other acquisition	$999,999 $1.15 p/Share	869,565 Added 32.45%	1,810,430 Common Stock
Apr 30 2025	BUY Grant, award, or other acquisition	-	79,504 Added 7.79%	940,865 Common Stock
Mar 24 2025	BUY Grant, award, or other acquisition	-	784,314 Added 47.66%	861,361 Common Stock
Jun 11 2024	BUY Grant, award, or other acquisition	-	41,143 Added 34.81%	77,047 Common Stock
Jun 06 2023	BUY Grant, award, or other acquisition	-	10,976 Added 23.41%	35,904 Common Stock
Jan 04 2023	BUY Exercise of in-the-money or at-the-money derivatives securities	-	1,574 Added 5.94%	24,928 Common Stock
Nov 19 2020	BUY Open market or private purchase	-	8,865 Added 27.51%	23,354 Common Stock
Nov 05 2020	BUY Grant, award, or other acquisition	-	14,489 Added 50.0%	14,489 Common Stock

Also insider at

ZNTL

Zentalis Pharmaceuticals, Inc. Healthcare

President, Interim CFO

Cam Gallagher

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUP shares.

Notify only if

Value

Insider Trading

Get notified when an Ocuphire Pharma, Inc. insider buys or sells OCUP shares.

Notify only if

Operation

Value

Type

News

Receive news related to Ocuphire Pharma, Inc.

Track Activities on OCUP

Account